… Introduction: Glaucoma constitutes a group of ocular diseases characterized byoptic nerve damage and loss of visual field, usually associated with elevated IOP. Although theelevation of IOP beyond normal values is not necessary for the occurrence of glaucomatousdamage, it is currently thought to be a major risk factor. Glaucoma is one of principal causes ofblindness in the world. The primary aim of POAG treatment is to prevent functional visualimpairment with in patient’s life time by slowing the rate of ganglion cell loss closer to that ofnormal population (approximately 5000/year). Medications for glaucoma have changed notablyover the past 2 decades with increase in efficacy, better dosing regimens, improvement in safety,and reduction in side-effects. Purpose of study: The purpose of this study is to compare the IOPlowering efficacy of the (Travatan) Travoprost 0.004%ophthalmic solution and (Alphagan)brimondine 0.2% ophthalmic solution in primary open angle glaucoma. Duration: The durationof study was six months from June 2009 to November 2009. Material and methods: The studywas conducted on 60 patients with primary open angle glaucoma (POAG) divided into twogroups randomly.. Each patient was examined regarding visual acuty, refraction, slit lampbiomicroscopy, IOP with Goldmann Applanation Tonometer, Gonioscopy, fundoscopy andPerimetry. Results: GROUP A had 30 patients with 60 eyes there were 25 male (83.33%) patientsand five females (16.67 %) patients. The eye drops travoprost 0.004 % one drop at night wasused. The average IOP reduction was 7mmhg from base line, GROUP B also had 30 patients with60 eyes there were 27 male (90%.) and 3 females (10 %) The eye drops brimonidine tartarate 0.2% was instilled twice a day one drop in the morning and one drop in the evening. The average IOPreduction was 5.5mmhg from base line. Conclusions: In conclusion both latanop
Purpose: To describe a new technique of suturing sclerotomy after 23- gauge pars plana vitrectomy using10 – 0 nylon suture with releasable knot. Study Design: Quasi experimental study. Place and Duration of Study: Sahiwal Teaching Hospital, Sahiwal, from January 2022 to June 2022. Methods: 10 – 0 nylon sutures with releasable knots were applied to close the sclerotomy after 23 – gauge pars plana vitrectomy in 100 cases. Complications like hypotony and wound leakage were recorded. Intra ocular pressures on 1st post-operative day and after 1 week were monitored. Inflammation at suture site, pain experienced by the patient and surgeon’s convenience of suture removal under a slit lamp after 1 week were documented. Results: Patients included 58 women and 42 men. Post-operatively, there was no wound leakage and hypotony in any patient, with mean intra ocular pressure of 13.5 ± 2.0 mmHg on 1st post-operative day and 17.6 ± .0.5 mmHg after 1 week of surgery. In 4% cases inflammation was observed at suture site. The mean pain score, measured according to visual analogue scale, at post-operative day 1 and day 7 was 1.25 ± 1.19 and 1.08 ± 0.99 respectively. No discomfort was reported during removal of releasable sutures in 96% of the patients. Surgeon found it convenient to remove the sutures under slit lamp illumination. Conclusion: Closure of 23 – gauge sclerotomy using nylon 10 – 0 suture with releasable knot is a useful option. It prevents post-operative wound leakage and hypotony.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.